Process to produce fibrillar proteins
    1.
    发明授权
    Process to produce fibrillar proteins 有权
    生产纤维蛋白的方法

    公开(公告)号:US08268974B2

    公开(公告)日:2012-09-18

    申请号:US12082634

    申请日:2008-04-11

    摘要: A method for changing a globular protein structure into a fibrillar protein structure. The method comprising the steps of providing a globular protein, forming a solution containing the globular protein, adding a detergent to the solution containing the globular protein, applying the solution to a molecular sizing column with a pore size of at least 70 kDa and eluting with a solution containing detergent. A method for changing an unfolded protein structure into a fibrillar protein structure. The method comprising the steps of providing a globular protein, forming a solution containing the globular protein, adding a urea to the solution to unfold the globular protein, applying the solution to a molecular sizing column and eluting with a solution containing detergent. A method for treating cancer comprising the steps of providing a protein, changing the protein into a fibrillar structure, and administering a therapeutically effective amount of the fibrillar structure protein to a patient in need thereof. A method for producing a vaccine adjuvant or antigen adjuvant comprising the steps of providing a protein, and changing the protein into a fibrillar structure.

    摘要翻译: 一种将球状蛋白结构变为纤维状蛋白结构的方法。 该方法包括以下步骤:提供球状蛋白质,形成含有球状蛋白质的溶液,向含有球状蛋白质的溶液中加入洗涤剂,将溶液施加到孔径至少为70kDa的分子筛分柱上,并用 含有洗涤剂的溶液。 将展开的蛋白质结构改变成纤维蛋白结构的方法。 该方法包括以下步骤:提供球状蛋白质,形成含有球状蛋白质的溶液,向溶液中加入尿素以展开球状蛋白质,将溶液施加到分子筛分柱上并用含有洗涤剂的溶液洗脱。 一种治疗癌症的方法,包括提供蛋白质,将蛋白质改变成纤维结构,以及向有需要的患者施用治疗有效量的纤维结构蛋白的步骤。 一种用于生产疫苗佐剂或抗原佐剂的方法,包括提供蛋白质并将蛋白质变成纤维结构的步骤。

    Process to produce fibrillar proteins and method of treatment using fibrillar proteins
    2.
    发明申请
    Process to produce fibrillar proteins and method of treatment using fibrillar proteins 有权
    生产纤维蛋白的方法和使用纤维蛋白的治疗方法

    公开(公告)号:US20080300186A1

    公开(公告)日:2008-12-04

    申请号:US12082634

    申请日:2008-04-11

    IPC分类号: A61K38/00 C07K1/00 A61P37/00

    摘要: A method for changing a globular protein structure into a fibrillar protein structure. The method comprising the steps of providing a globular protein, forming a solution containing the globular protein, adding a detergent to the solution containing the globular protein, applying the solution to a molecular sizing column with a pore size of at least 70 kDa and eluting with a solution containing detergent. A method for changing an unfolded protein structure into a fibrillar protein structure. The method comprising the steps of providing a globular protein, forming a solution containing the globular protein, adding a urea to the solution to unfold the globular protein, applying the solution to a molecular sizing column and eluting with a solution containing detergent. A method for treating cancer comprising the steps of providing a protein, changing the protein into a fibrillar structure, and administering a therapeutically effective amount of the fibrillar structure protein to a patient in need thereof. A method for producing a vaccine adjuvant or antigen adjuvant comprising the steps of providing a protein, and changing the protein into a fibrillar structure.

    摘要翻译: 一种将球状蛋白结构变为纤维状蛋白结构的方法。 该方法包括以下步骤:提供球状蛋白质,形成含有球状蛋白质的溶液,向含有球状蛋白质的溶液中加入洗涤剂,将溶液施加到孔径至少为70kDa的分子筛分柱上,并用 含有洗涤剂的溶液。 将展开的蛋白质结构改变成纤维蛋白结构的方法。 该方法包括以下步骤:提供球状蛋白质,形成含有球状蛋白质的溶液,向溶液中加入尿素以展开球状蛋白质,将溶液施加到分子筛分柱上并用含有洗涤剂的溶液洗脱。 一种治疗癌症的方法,包括提供蛋白质,将蛋白质改变成纤维结构,以及向有需要的患者施用治疗有效量的纤维结构蛋白的步骤。 一种用于生产疫苗佐剂或抗原佐剂的方法,包括提供蛋白质并将蛋白质变成纤维结构的步骤。

    PROCESS TO PRODUCE FIBRILLAR PROTEINS AND METHOD OF TREATMENT USING FIBRILLAR PROTEINS
    3.
    发明申请
    PROCESS TO PRODUCE FIBRILLAR PROTEINS AND METHOD OF TREATMENT USING FIBRILLAR PROTEINS 有权
    生产纤维蛋白的方法和使用纤维蛋白的治疗方法

    公开(公告)号:US20120316117A1

    公开(公告)日:2012-12-13

    申请号:US13572652

    申请日:2012-08-12

    IPC分类号: A61K38/38 A61P35/00

    摘要: A method for inhibiting survival of cancer cells in a subject is disclosed. The method comprises administering to a subject in need thereof a therapeutically effective amount of fibrillar albumin. The preparation of the fibrillar albumin comprises: (i) forming a solution comprising an isolated and/or purified globular albumin; (ii) adding a detergent to the solution containing the isolated and/or purified globular albumin, wherein the detergent is one selected from the group consisting of sodium dodecyl sulfate (SDS) and n-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate; (iii) applying the solution to a molecular sizing column with a pore size that permits separation of a protein with a molecular weight of at least about 70 kDa so as to promote column-induced formation of the fibrillar albumin from the isolated and/or purified globular albumin; and (iv) eluting the fibrillar albumin from the column, wherein the eluted albumin has a fibrillar structure.

    摘要翻译: 公开了抑制受试者中癌细胞存活的方法。 该方法包括向有需要的受试者施用治疗有效量的原纤维白蛋白。 纤维状白蛋白的制备包括:(i)形成包含分离和/或纯化的球状白蛋白的溶液; (ii)向含有分离和/或纯化的球状白蛋白的溶液中加入洗涤剂,其中洗涤剂选自十二烷基硫酸钠(SDS)和正十四烷基-N,N-二甲基-3-氨基 -1-丙磺酸盐; (iii)将溶液施加到具有允许分离至少约70kDa的分子量的蛋白质的孔径的分子筛分柱,以便促进来自分离和/或纯化的柱状诱导的纤维状白蛋白的形成 球状白蛋白 和(iv)从柱中洗脱纤维状白蛋白,其中洗脱的白蛋白具有纤维状结构。

    Fibrillar albumin for use in inhibiting cancer growth
    4.
    发明授权
    Fibrillar albumin for use in inhibiting cancer growth 有权
    用于抑制癌症生长的纤维白蛋白

    公开(公告)号:US08685923B2

    公开(公告)日:2014-04-01

    申请号:US13572652

    申请日:2012-08-12

    IPC分类号: A61K38/38 C07K14/76 C07K1/16

    摘要: A method for inhibiting survival of cancer cells in a subject is disclosed. The method comprises administering to a subject in need thereof a therapeutically effective amount of fibrillar albumin. The preparation of the fibrillar albumin comprises: (i) forming a solution comprising an isolated and/or purified globular albumin; (ii) adding a detergent to the solution containing the isolated and/or purified globular albumin, wherein the detergent is one selected from the group consisting of sodium dodecyl sulfate (SDS) and n-tetradecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate; (iii) applying the solution to a molecular sizing column with a pore size that permits separation of a protein with a molecular weight of at least about 70 kDa so as to promote column-induced formation of the fibrillar albumin from the isolated and/or purified globular albumin; and (iv) eluting the fibrillar albumin from the column, wherein the eluted albumin has a fibrillar structure.

    摘要翻译: 公开了抑制受试者中癌细胞存活的方法。 该方法包括向有需要的受试者施用治疗有效量的原纤维白蛋白。 纤维状白蛋白的制备包括:(i)形成包含分离和/或纯化的球状白蛋白的溶液; (ii)向含有分离和/或纯化的球状白蛋白的溶液中加入洗涤剂,其中洗涤剂选自十二烷基硫酸钠(SDS)和正十四烷基-N,N-二甲基-3-氨基 -1-丙磺酸盐; (iii)将溶液施加到具有允许分离至少约70kDa的分子量的蛋白质的孔径的分子筛分柱,以便促进来自分离和/或纯化的柱状诱导的纤维状白蛋白的形成 球状白蛋白 和(iv)从柱中洗脱纤维状白蛋白,其中洗脱的白蛋白具有纤维状结构。

    SUPPRESSION OF CANCER METASTASIS
    10.
    发明申请
    SUPPRESSION OF CANCER METASTASIS 审中-公开
    抑制癌症分期

    公开(公告)号:US20120309682A1

    公开(公告)日:2012-12-06

    申请号:US13510753

    申请日:2010-11-19

    IPC分类号: A61K38/38 A61P35/04 A61K38/16

    摘要: Methods are provided for suppressing cancer metastasis. Cancer metastasis is the most common cause of treatment failure and death in cancer patients. Tumor cell invasion and/or migration can be significantly inhibited after fibrillar proteins (rVP1, F-HSA, and F-BSA) treatment in vitro. In addition, rVP1 can significantly suppress murine and human breast cancer metastasis and human prostate and ovarian cancer metastasis in vivo while F-HSA can significantly suppress murine breast cancer metastasis. Compositions of fibrillar proteins as anti-cancer metastasis therapeutics and methods of use thereof are provided herein.

    摘要翻译: 提供抑制癌症转移的方法。 癌症转移是癌症患者治疗失败和死亡的最常见原因。 在纤维状蛋白(rVP1,F-HSA和F-BSA)体外处理后,可以显着抑制肿瘤细胞侵袭和/或迁移。 另外,rVP1可以显着抑制鼠体内人乳腺癌转移和人前列腺癌和卵巢癌转移,而F-HSA可显着抑制鼠乳腺癌转移。 本文提供了作为抗癌转移治疗剂的原纤维蛋白的组合物及其使用方法。